Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

OCT 22, 2014 - Benzinga

A Must Read - Share

Harvoni Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute

U.S. Food and Drug Administration (FDA) announced October 10, 2014 that Gilead Sciences Harvoni® (ledipasvir/sofosbuvir) product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults.

Tags: Harvoni Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute,  Gilead Sciences Latest News

OCT 22, 2014 - TheStreet

A Must Read - Share

Despite Stock Market Rally Many Opportunities Still Exist

NEW YORK (TheStreet) --aAfter the market's 10% selloff and subsequent rally, there are still a few buying opportunities left, said Stephen Weiss, founder and managing partner of Short Hills Capital Partners LLC.a On Wednesday's CNBC's "Fast Money Halftime Report he said he specifically likes airline stocks because of falling fuel costs, as well as portfolio protection via a long position ...

Tags: Despite Stock Market Rally Many Opportunities Still Exist,  Gilead Sciences Latest News

OCT 16, 2014 - Business Insider

A Must Read - Share

Top Investors, Strategists Take Pummeling In Wall St Sell-off

By Svea Herbst-BaylissBOSTON (Reuters) - Some of Wall Street’s biggest names are licking their wounds as October lives up to its reputation as one of the market’s roughest months.The Standard & Poor's 500 index  has now lost almost 8 percent in the past three-and-a-half weeks , wiping out almost all of the gains achieved earlier in 2014. What seemed like ...

Tags: Top Investors, Strategists Take Pummeling In Wall St Sell-off,  Gilead Sciences Latest News

OCT 15, 2014 - TheStreet

A Must Read - Share

Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental

Some perspective on recent positive news, which nonetheless, caused Seattle Genetics and Gilead shares to fall. Click to view a price quote on SGEN. Click to research the Drugs industry.

Tags: Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental,  Gilead Sciences Latest News

OCT 15, 2014 - TheStreet

A Must Read - Share

Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths

I want to step back and provide some perspective on recent news from Seattle Genetics and Gilead Sciences , two stocks I'm bullish on and own personally. On Sept. 29, Seattle Genetics reported the long awaited results from the "AETHERA" studyaof Adcetris as a "maintenance" treatment for Hodgkin's lymphoma. In the study, Adcetris showed a very robust effect with a ...

Tags: Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths,  Gilead Sciences Latest News